A. Tran

1.1k total citations
15 papers, 801 citations indexed

About

A. Tran is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health. According to data from OpenAlex, A. Tran has authored 15 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Pediatrics, Perinatology and Child Health and 5 papers in Psychiatry and Mental health. Recurrent topics in A. Tran's work include Epilepsy research and treatment (5 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Neutropenia and Cancer Infections (3 papers). A. Tran is often cited by papers focused on Epilepsy research and treatment (5 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Neutropenia and Cancer Infections (3 papers). A. Tran collaborates with scholars based in France, United States and Cameroon. A. Tran's co-authors include Gérard Pons, Elisabeth Rey, Jean‐Louis Vincent, P D’Athis, Catherine Chiron, Olivier Dulac, Jean‐Marc Tréluyer, François Goldwasser, Vincent Jullien and V. Girre and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

A. Tran

15 papers receiving 779 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Tran France	9	436	371	222	151	127	15	801
Takateru Ishitsu Japan	17	425 1.0×	474 1.3×	273 1.2×	170 1.1×	39 0.3×	29	767
Sarah K. Tate United Kingdom	7	324 0.7×	298 0.8×	186 0.8×	251 1.7×	96 0.8×	8	805
Martine Guyot France	11	430 1.0×	387 1.0×	77 0.3×	38 0.3×	126 1.0×	14	666
Pascal Espié Switzerland	12	108 0.2×	135 0.4×	92 0.4×	106 0.7×	74 0.6×	21	625
Nathalie Toublanc Belgium	11	376 0.9×	349 0.9×	62 0.3×	67 0.4×	170 1.3×	18	646
Maria Laura Sargentini‐Maier Belgium	15	516 1.2×	505 1.4×	108 0.5×	83 0.5×	286 2.3×	21	783
L. Maskell United Kingdom	8	77 0.2×	235 0.6×	391 1.8×	156 1.0×	83 0.7×	10	767
Lu Yu China	15	119 0.3×	57 0.2×	353 1.6×	297 2.0×	45 0.4×	45	965
Patricia Bricmont United States	16	159 0.4×	99 0.3×	109 0.5×	231 1.5×	19 0.1×	18	665
Betsy Williams United States	16	587 1.3×	519 1.4×	93 0.4×	220 1.5×	364 2.9×	50	999

Countries citing papers authored by A. Tran

Since Specialization

Citations

This map shows the geographic impact of A. Tran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Tran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Tran more than expected).

Fields of papers citing papers by A. Tran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Tran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Tran. The network helps show where A. Tran may publish in the future.

Co-authorship network of co-authors of A. Tran

This figure shows the co-authorship network connecting the top 25 collaborators of A. Tran. A scholar is included among the top collaborators of A. Tran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Tran. A. Tran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Tran, A., et al.. (2025). Recombinant human DNase treatment mitigates extracellular trap mediated damage and improves long-term recovery after spinal cord injury in male mice. Brain Behavior and Immunity. 128. 456–468. 2 indexed citations

Zhang, Wei, Shaoqing He, A. Tran, et al.. (2023). The endothelin receptor antagonist macitentan ameliorates endothelin-mediated vasoconstriction and promotes the survival of retinal ganglion cells in rats. SHILAP Revista de lepidopterología. 3. 4 indexed citations

Mir, Olivier, J. Alexandre, A. Tran, et al.. (2009). Relationship between GSTP1 Ile105Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity. Annals of Oncology. 20(4). 736–740. 70 indexed citations

Alexandre, J., Elisabeth Rey, V. Girre, et al.. (2006). Relationship between cytochrome 3A activity, inflammatory status and the risk of docetaxel-induced febrile neutropenia: a prospective study. Annals of Oncology. 18(1). 168–172. 51 indexed citations

Tran, A., Vincent Jullien, J M Alexandre, et al.. (2006). Pharmacokinetics and toxicity of docetaxel: Role of CYP3A, MDR1, and GST polymorphisms. Clinical Pharmacology & Therapeutics. 79(6). 570–580. 117 indexed citations

Tran, A., et al.. (2005). Inhibitory effect of stiripentol on clobazam metabolism by cDNA-expressed human CYP. Clinical Pharmacology & Therapeutics. 77(2). P49–P49. 1 indexed citations

Jouan, Marc, Vincent Jullien, Tetanye Ekoe, et al.. (2005). Quinine Pharmacokinetics and Pharmacodynamics in Children with Malaria Caused by Plasmodium falciparum. Antimicrobial Agents and Chemotherapy. 49(9). 3658–3662. 15 indexed citations

Alexandre, J M, V. Diéras, Sophie Grabar, et al.. (2005). Prospective study of predictive factors of docetaxel (DCX)-induced febrile neutropenia (FN): Relevance of in vivo cytochrome 3A (CYP3A) phenotyping. Journal of Clinical Oncology. 23(16_suppl). 2046–2046. 1 indexed citations

Tran, A., Jean‐Marc Tréluyer, Elisabeth Rey, et al.. (2003). Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human. British Journal of Clinical Pharmacology. 56(5). 526–536. 37 indexed citations

10.

Rey, Elisabeth, Catherine Chiron, Merçè Brunet, et al.. (2003). Stiripentol (STP) in Childhood Partial Epilepsy: A Randomized Placebo‐Controlled Trial With An Enrichment and Withdrawal Design. Clinical Pharmacology & Therapeutics. 73(2). 2 indexed citations

11.

Tran, A.. (2002). Pharmacokinetic-pharmacodynamic study of oral lansoprazole in children. Clinical Pharmacology & Therapeutics. 71(5). 359–367. 36 indexed citations

12.

Chiron, Catherine, A. Tran, Elisabeth Rey, et al.. (2000). Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. The Lancet. 356(9242). 1638–1642. 413 indexed citations

13.

Tran, A., et al.. (1998). Vigabatrin:placental transfer ‘ooin vivo‘ox and excretion into breast milk of the enantiomers. British Journal of Clinical Pharmacology. 45(4). 409–411. 25 indexed citations

14.

Tran, A., F Vauzelle-Kervroëdan, Elisabeth Rey, et al.. (1996). Effect of stiripentol on carbamazepine plasma concentration and metabolism in epileptic children. European Journal of Clinical Pharmacology. 50(6). 497–500. 24 indexed citations

15.

Tran, A., D Vanhée, A Capron, et al.. (1992). Separate induction of human blood platelet aggregation or cytotoxicity by different concentrations of PAF-acether and thrombin. Inflammation Research. 36(1-2). 39–43. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact